Zantac / Ranitidine (NDMA Cancer) Attorney in Sacramento, California

Preparing your case review…
Sacramento Data

Zantac / Ranitidine (NDMA Cancer) Statistics in Sacramento

~2.4 million

Sacramento Metro Population

~250

Est. Annual Bladder Cancer Diagnoses (Sacramento County)

Frye/Kelly (favorable vs. Daubert)

CA Expert Standard

~200,000 state workers — CalPERS pharmacy records available

State Government Employment

Local Courts

Courts in Sacramento, California

Sacramento County Superior Court

720 9th St, Sacramento, CA 95814

U.S. District Court, Eastern District of California — Sacramento Division

501 I St, Sacramento, CA 95814

Medical Facilities

Hospitals & Trauma Centers in Sacramento

UC Davis Comprehensive Cancer Center

4501 X St, Sacramento, CA 95817

Dignity Health Mercy Medical Center — Cancer Services

4001 J St, Sacramento, CA 95819

Liability Overview

Liability Considerations in Sacramento

Zantac Litigation in Sacramento

Sacramento's large state government workforce represents a demographic with comprehensive pharmacy benefit records through CalPERS — making prescription ranitidine documentation particularly robust. Sacramento County Superior Court applies California's Frye/Kelly standard, which has been applied more favorably than Daubert for Zantac causation experts. UC Davis Comprehensive Cancer Center provides world-class cancer documentation. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Sacramento Zantac Claimants

Sacramento-area Zantac claimants should obtain CalPERS prescription records (for state employees), as well as pharmacy records from Safeway, Raley's, Walgreens, and CVS. UC Davis Cancer Center and Dignity Health records documenting bladder, esophageal, stomach, or colorectal cancer diagnoses are critical evidence. California's 2-year SOL with the favorable Frye/Kelly standard makes California state court a viable primary venue.

The Team

Your Legal Team

DO

Diana Okafor

Partner

Los Angeles, CA

18+ Years Experience
Product liability — pharmaceuticalsCalifornia state court mass tort litigationNDMA and ranitidine cancer casesFailure to warn and design defect claims

Diana Okafor is one of California's leading pharmaceutical product liability attorneys, with 18 years of experience litigating drug injury cases in California state courts. She has been at the forefront of Zantac litigation in California since 2021, successfully defeating multiple Frye/Kelly challenges to general causation experts — challenges modeled on the Daubert motions that closed the federal MDL. Diana's scientific background in molecular biology informs her cross-examination of defense experts and her direct examination of oncologists and toxicologists. She has handled over 400 Zantac cancer cases and has secured multiple seven-figure outcomes for California clients. Diana is a frequent lecturer on pharmaceutical mass tort strategy at California state bar continuing legal education programs.

Education

  • J.D., UCLA School of Law (2008)
  • B.A., Molecular Biology, UC San Diego (2005)